Edition:
India

Apellis Pharmaceuticals Inc (APLS.OQ)

APLS.OQ on NASDAQ Stock Exchange Global Select Market

28.28USD
23 Jul 2019
Change (% chg)

-- (--)
Prev Close
$28.28
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
128,004
52-wk High
$29.49
52-wk Low
$11.45

About

Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the discovery and development of therapeutic compounds for autoimmune and inflammatory diseases. The Company's lead compounds are designed to inhibit complement component 3 (C3), the central protein in the complement cascade. The... (more)

Overall

Beta: --
Market Cap(Mil.): $1,788.21
Shares Outstanding(Mil.): 63.23
Dividend: --
Yield (%): --

Financials

  APLS.OQ Industry Sector
P/E (TTM): -- 30.58 34.39
EPS (TTM): -2.77 -- --
ROI: -68.89 13.01 12.67
ROE: -88.38 14.16 17.18

Earnings vs. Estimates